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Angiotensin II (Ang II) activates at least two receptors,
AT1 and AT2, with the majority of its effects—such
as vasoconstriction, inflammation, and matrix
deposition—mediated by the AT1 receptor. It is thought that
the AT2 receptor counteracts these processes; however,
recent studies have found proinflammatory and hypertrophic
effects of this receptor subtype. To identify the physiological
roles of the AT2 receptor in chronic kidney disease, we
performed renal ablation in AT2 receptor knockout and wild-
type mice. Renal injury caused a greater impairment of renal
function, glomerular injury, albuminuria, and mortality in the
knockout mice than in the wild-type mice. There was
increased fibronectin expression and inflammation in the
knockout mice, as shown by augmented monocyte/
macrophage infiltration and higher chemokine monocyte
chemotactic protein-1 (MCP-1) and RANTES expression in the
remnant kidney. The higher mortality and renal morbidity of
the knockout mice was not due to differences in systemic
blood pressure, glomerular volume, AT1 receptor, renin, or
endothelial nitric oxide synthase expression. Whether
activation of the AT2 receptor will have therapeutic benefit in
chronic kidney disease will require further study.
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Almost all classical angiotensin II (Ang II)-induced func-
tions, such as vasoconstriction, aldosterone release, stimula-
tion of tubular transport, pro-inflammatory effects, as well as
fibrogenic and growth-stimulatory actions, are mediated by
the AT1 receptor.1 Experimental and clinical studies using
AT1 antagonists, as well as studies in AT1a receptor knockout
mice, indicate the involvement of the AT1 receptor in the
progression of chronic kidney disease.2 The function of the
AT2 receptor is less clear, but it has been proposed that
activation of this receptor antagonizes those functions that
are mediated by the AT1 receptor, providing negative
feedback control.3 Along this line, it has been shown that
activation of the AT2 receptor decreases blood pressure,
inhibits growth, induces differentiation, and even mediates
apoptosis.4 However, this conception has been partly
questioned by recent data that have suggested that the AT1
and AT2 receptors may also share some signaling pathways.5
Recent evidence indicates that cell hypertrophy and pro-
inflammatory effects mediated through activation of the
transcription factor, NFkappaB, are also transduced by AT2
receptor activation.6–8 Further evidence for potentially
adverse effects of AT2 receptor stimulation is provided by
in vivo studies showing that AT2 receptor blockers exhibit
anti-inflammatory effects in models of renal injury.9,10
Hence, to date, the role of the AT2 receptor in chronic
kidney disease remains elusive. The renal ablation model,
achieved by unilateral nephrectomy and the removal of two-
thirds of the contralateral kidney, has been extensively and
successfully used to study the pathogenesis, as well as the
effectiveness, of pharmacological intervention on renal
injury.11
Therefore, we directly examined the role of the AT2
receptor in renal injury, inflammation, and fibrosis in this
study. Using the well-characterized model of renal ablation,
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we found increased renal injury, proteinuria, and mortality in
the AT2 receptor-deficient mice indicating that stimulation of
the AT2 receptor exerts beneficial effects in chronic kidney
disease.
RESULTS
Body and kidney weight
No significant difference in body weight was found between
knockout and wild-type mice at the time of surgery
(knockout: 32.9±0.9 vs wild-type: 32.1±1.3 g). The ratio
between of removed kidney tissue weight and total body
weight was comparable between wild-type and knockout
mice (knockout 2.3±0.08 vs wild-type 2.4±0.09 mg/g),
indicating that the surgical procedure to induce renal injury
yielded similar results in both groups. At the end of the
experiment, a slightly decreased body weight was found in
the knockout as compared with wild-type mice after renal
ablation (knockout: 31.7±0.78 vs wild-type: 34.0±0.59 g,
Po0.05). However, no significant difference was found in the
weight of the remaining kidney between wild-type and
knockout mice after renal ablation (knockout: 6.4±0.28 vs
wild-type: 6.9±0.30 mg/g; P¼ 0.28).
Survival
Mortality started B4–6 weeks after renal ablation, and a
significantly higher mortality rate was observed in knockout
as compared with wild-type mice after renal ablation, as
shown in Figure 1 (66.7 vs 28.6% mortality, Po0.01 (logrank
test), n¼ 21/21).
Histology
No renal abnormality was found in knockout control mice as
compared with wild-type control mice confirming earlier
reports.12 In contrast, after renal ablation, heavy focal and
segmental injury with plasma insudation, endothelial injury,
vacuoles, capillary obsolescence, and matrix expansion were
found in the glomeruli of the knockout mice, whereas only
mild changes were observed in wild-type mice after renal
ablation. It is worth noting that no difference was found
regarding the type of glomerular injury between knockout
and wild-type mice. However, the injury was more
pronounced in knockout mice (Figure 2a). As alterations in
the maturation of the ureter during development have been
described with low incidence in AT2 receptor knockout
mice,13 all kidneys were macroscopically and microscopically
examined but none showed signs of hydronephrosis.
Semiquantitative analysis of glomerular injury by scoring is
shown in Figure 2b.
Gene expression in renal cortex
We have earlier shown that expression of fibronectin
measured by real-time reverse transcriptase-PCR from whole
renal cortex correlates well with renal injury in mice.14 Real-
time reverse transcriptase-PCR analyses of mRNA from
whole kidney cortex reflected the enhanced renal injury in
knockout mice after renal ablation by showing a significantly
increased expression of fibronectin (Figure 3).
Albuminuria
Wild-type and knockout mice both developed albuminuria
after ablation, but albuminuria was more pronounced and
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Figure 1 | Analysis of mortality. A significant increase in
mortality was found in knockout compared with wild-type mice
after renal ablation. Two months after renal ablation 66.7% of AT2
receptor-deficient mice were dead, whereas only 28.6% mortality
was observed in wild-type mice (Po0.01 logrank test; n¼ 21/21).
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Figure 2 | Renal injury. Representative examples of glomerular
morphology showed by periodic acid Schiff staining (630-fold
magnification, oil). Severe glomerular injury was found in
knockout mice and only mild changes were found in wild-type
mice after renal ablation (a). Analysis of glomerular injury by
scoring is shown in (b).
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significantly higher in knockout mice, as shown in Figure 4a.
As a morphological correlate of the increased proteinuria in
knockout mice, the examination of periodic acid Schiff-
stained kidney sections showed proteinaceous casts in a large
number of tubuli in the knockout group, whereas casts were
only rarely observed in the wild-type mice after renal ablation
(Figure 4b). No cast was found in wild-type and knockout
mice without surgery. Quantitative analysis is shown in
Figure 4c.
Renal function
Plasma creatinine and urea-N significantly increased after
renal ablation. In addition, significantly higher plasma values
of creatinine and urea-N were observed in knockout as
compared with wild-type mice, thereby indicating stronger
impairment of renal function in the knockout mice after
renal ablation (Table 1).
Inflammation
The increased glomerular injury observed in knockout mice
was accompanied by significantly increased glomerular and
interstitial infiltration of monocytes/macrophages in knock-
out as compared with that in wild-type mice after renal
ablation (Figure 5a and b). Given the increased infiltration of
monocyte/macrophages into the remnant kidneys of knock-
out mice, we carried out real-time reverse transcriptase-PCR
mRNA expression analyses of the chemokines, monocyte
chemotactic protein-1 (MCP-1) and regulated on activation,
normal T-cell expressed and secreted (cytokine) (RANTES),
in mRNA derived from whole kidney cortex. A significantly
higher expression was found in the knockout mice as
compared with that observed in the wild-type mice after
ablation (Figure 5c and d). To analyze the cellular origin of
the upregulated MCP-1 mRNA, we carried out in situ
hybridization studies. In situ hybridization showed very low
MCP-1 expression in wild-type and knockout control mice,
whereas an increased expression was found in the cortex of
wild-type mice after ablation. This was further increased in
the knockout mice as shown by the autoradiographs
confirming the PCR data (Figure 5e). A higher magnification
showed expression of MCP-1 in Bowman’s capsule and in the
periglomerular region. In addition, a strong intraglomerular
MCP-1 expression was found. Furthermore, expression was
found in interstitial infiltrates and especially in and around
dilatated tubuli (Figure 5f). This expression pattern over-
lapped with the histological pattern of infiltrating mono-
cytes/macrophages.
We next examined possible causes for the enhanced renal
injury in knockout mice by studying blood pressure, Ang II
receptor expression, podocyte and basal membrane structure,
glomerular hypertrophy, renin, and endothelial nitric oxide
(NO) synthase (eNOS) expression.
Blood pressure
No significant difference was found in systolic blood pressure
(SBP) between wild-type and knockout mice confirming the
earlier reports in this strain.12 Systolic blood pressure
increased slightly after renal ablation in both groups.
However, this increase was not statistically significant as
compared with controls, confirming earlier studies that renal
ablation in mice is a non-hypertensive model of chronic
kidney disease.15 In addition, systolic blood pressure was
similar in wild-type and knockout mice after renal ablation
(Figure 6a). The plethysmographical blood pressure data
after renal ablation were confimed by radiotelemetrical
analyses. The mean arterial blood pressure after renal
ablation was similar in AT2 knockout and wild-type mice,
indicating that differences in systemic blood pressure are not
the cause for the increased renal morbidity in AT2 knockout
mice observed in this study 4 weeks after renal ablation
(Figure 6b). The continuous recording of systolic and
diastolic blood pressure after induction of chronic renal
failure (Figure 6c) and the analysis of the weekly average of
mean blood pressure (Figure 6d) showed a non-significant
trend towards increasing blood pressure in knockout mice 6
weeks after renal ablation, which may reflect increasing
chronic kidney damage occurring in this genotype. It is
noteworthy that albuminuria and glomerular injury were
examined in this study 4 weeks after renal ablation. Similar
activity and heart rates were observed in knockout as
compared with wild-type mice throughout the observational
period (Figure 6e and f).
Ang II receptor expression
We next asked whether upregulation of the AT1a receptor
might have rendered the kidney more sensitive to the
deleterious effects of Ang II after renal ablation. A slightly
but significantly higher expression of AT1a receptor
mRNA expression was found in knockout as compared with
wild-type controls. The AT1 receptor mRNA expression
increased significantly in wild-type and knockout mice after
renal ablation. However, the difference between both
genotypes after renal ablation was not significant (Table 2). In
contrast, as far as the AT1 receptor protein expression is
concerned, no difference between knockout and wild-type mice
was detected before and after renal ablation (data not shown).
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Figure 3 | Quantification of gene expression. Real-time RT-PCR
analyses of mRNA from whole kidney cortex showed a pro-fibrotic
pattern in knockout mice as underlined by increased mRNA
expression of fibronectin.
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Electron microscopy
An electron microscopy analysis showed that the heavy
proteinuria found in the knockout mice after renal ablation
was not associated with an ultrastructural evidence of
podocyte or basal membrane damage (Figure 7).
Glomerular size
Glomerular hypertrophy is an important parameter con-
tributing to the progression of chronic kidney disease.16 No
significant difference was found between wild-type and
knockout mice. The glomerular size increased after renal
ablation in the knockout mice; however, no significant
difference was found between wild-type and knockout mice
after renal ablation, as shown in Figure 8.
Renin, eNOS expression, and asymmetric dimethylarginine
(ADMA)
The recent cloning of a (pro)renin receptor suggests that
renin may have direct toxic effects.17 Signal transduction by
the AT2 receptor has been reported to inhibit renal-renin
synthesis.18 We therefore studied the renin expression in
wild-type and knockout mice; however, no significant
differences was found among the four groups (Figure 9a).
Recent in vitro and in vivo data suggest that induction of
eNOS expression by Ang II is transduced by the AT2 receptor
and that cardiac hypertrophy in the AT2 receptor knockout
mice is caused by decreased eNOS expression.19 Moreover,
decreasing bioavailability of eNOS-derived NO aggravates
glomerular injury.20 We therefore examined whether failure
to increase eNOS expression in response to renal ablation
may have caused the increased renal injury in the AT2
receptor knockout mice. However, as shown in Figure 9, no
significant difference was found for eNOS mRNA expression
between wild-type and knockout controls. In addition, eNOS
mRNA expression increased even higher in knockout than in
wild-type mice after renal ablation. To further elucidate this
matter, we investigated the plasma concentrations of an
important endogenous inhibitor of nitric oxide synthases,
ADMA, which has been shown to accumulate in renal failure
and may, by this means, impair protective eNOS function-
ality in the failing kidney. ADMA increased slightly, but not
significantly, in wild-type mice after renal ablation. In
contrast, a significant increase was found in the knockout
mice after renal ablation compared with knockout without
renal ablation and compared with wild-type mice after renal
ablation (Figure 9c). Moreover, the symmetric analogon of
ADMA, symmetric dimethylarginine, which has been identi-
fied as a sensitive marker of renal impairment but is a far less-
potent inhibitor of NOS, showed an even more pronounced
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Figure 4 | Proteinuria. Pronounced albuminuria was found in knockout mice, whereas wild-type mice developed only mild albuminuria
after renal ablation as shown in (a). The heavy proteinuria in knockout mice was matched by an increased number of proteinaceous casts on
PAS-stained kidney sections (b, 200-fold magnification). Quantitative analysis of the protein casts is shown in (c).
Table 1 | Renal function in knockout and wild-type mice 4
weeks after renal ablation
Plasma creatinine
(mg/100 ml)
Plasma urea-N
(mg/100 ml)
Controls wild-type 0.13±0.01 21±1
Controls knockout 0.12±0.01 21±1
Ablation wild-type 0.18±0.02* 47±3**
Ablation knockout 0.29±0.06**,# 70±9**,#
*Po0.05, **Po0.001 vs controls, #Po0.05 vs ablation wild-type.
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increase after renal ablation in both genotypes, but
significantly greater in ablated knockout mice (Figure 9d).
In contrast, no difference was found in ADMA and
symmetric dimethylarginine plasma levels between untreated
wild-type and knockout mice.
DISCUSSION
Proteinuria and glomerular injury, characterized by capillary
obsolescence and increased extracellular matrix accumula-
tion, are the final common pathways in a variety of renal
pathologies leading to chronic kidney disease. Ang II plays an
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Figure 5 | Inflammation. An increased glomerular and interstitial infiltration of monocytes/macrophages was found in knockout mice (a, b).
The increased infiltration of monocytes/macrophages was accompanied by an increased expression of the chemokines MCP-1 and RANTES
in knockout mice (c, d). The increased expression was confirmed by intense staining for MCP-1 in autoradiographs of whole kidney slices (e).
Higher magnification showed intraglomerular and periglomerular MCP-1 expression as well as interstitial and tubular expression (f).
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important role in the progression of chronic kidney disease.
An AT1 and an AT2 subtype of the Ang II receptor have been
described. To date, no comprehensive study has investigated
the role of the AT2 receptor on morbidity and mortality in
chronic kidney disease. In this study, we used AT2 receptor
knockout (knockout) mice on an FVB/N background, as this
strain is susceptible to kidney injury after renal ablation and
develops renal morbidity and mortality. We observed that the
knockout mice were more susceptible to renal ablation and
suffered a significant increase in mortality relative to the
wild-type mice. We used a number of quantitative and
semiquantitative measures to gauge the extent of renal injury
in knockout mice as compared with that observed in wild-
type mice. Renal injury, as assessed by scoring glomerular
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Figure 6 | Blood pressure. No significant difference was found for systolic blood pressure between wild-type and knockout control mice or
between wild-type and knockout mice after renal ablation as assessed by tail cuff plethysmography (a). In addition, in a second set of
experiments measurement of arterial blood pressure after renal ablation by radiotelemetry showed no significant difference in the average
mean arterial blood (MAP) pressure between knockout and wild-type mice after renal ablation (b). Continuous recording of systolic and
diastolic blood pressure after induction of chronic renal failure (c) and analysis of weekly average of mean blood pressure (d) showed no
significant difference. Similar activity and heart rates were observed in knockout as compared with wild-type mice throughout the
observational period (e, f). The data are from six wild-type mice and five knockout mice. One device in the knockout group had a technical
failure in the fifth week after renal ablation, therefore reducing the analysis to n¼ 4 in the sixth week.
Table 2 | AT1a mRNA expression in the kidney 4 weeks after
renal ablation
mRNA AT1a receptor
Controls wild-type 100±8
Controls knockout 130±2#
Ablation wild-type 168±21*
Ablation knockout 273±50*
#Po0.05 vs control wild-type, *Po0.05 vs controls (arbitrary units).
Renal
ablation
Controls
Wild-type Knockout
Figure 7 | Electron microscopy. Micrographs of kidneys from
wild-type and knockout control as well as from wild-type and
knockout mice after renal ablation are shown. Analysis of the
detailed glomerular ultrastructure shows no podocyte damage or
glomerular basement membrane alterations in the knockout mice
(magnification  7000).
1044 Kidney International (2009) 75, 1039–1049
o r i g i n a l a r t i c l e RA Benndorf et al.: Renal injury in AT2 receptor–deficient mice
changes in periodic acid Schiff-stained renal sections, was
confirmed by the upregulation of fibronectin, indicating
enhanced renal damage in the knockout mice. In addition,
enhanced glomerular and interstitial monocyte/macrophage
infiltration and, as a marker of inflammation, increased
induction of the chemokines, MCP-1 and RANTES, were
found in the knockout mice as compared with wild-type mice
after renal ablation. Finally, as a histological correlate for the
increased proteinuria in the knockout mice, numerous
proteinaceous casts were found in the kidneys of the
knockout mice.
Our results are in line with recent data showing
acceleration of renal injury in AT2 receptor knockout mice
during unilateral ureteral obstruction.21 However, the uni-
lateral-ureteral obstruction model does not allow for the
examination of renal function, proteinuria, or survival. Our
data are also supported by recent findings from Hashimoto
and associates, who showed that overexpression of the AT2
receptor in vascular smooth muscle cells has protective effects
in 5 of 6 nephrectomized mice.22 However, in their study 5 of
6 nephrectomy was carried out in C57BL/6 mice, which
develop only very mild glomerular changes after renal
ablation.15
On the basis of the data presented within this paper, we
propose a clearly beneficial role of the AT2 receptor in the
pathogenesis of chronic kidney disease. However, conflicting
results have been published regarding the effect of AT2
receptor antagonists in rats with renal ablation. Vazquez et al.
observed an increase in blood pressure and renal injury in
PD123,319-treated rats after renal ablation. In contrast, Cao
et al.10,23 showed a beneficial effect of this compound in rats
in the same model. Similarly, Esteban et al.9 observed
decreased inflammatory cell infiltration in the unilateral
ureteral obstruction model after treatment with PD123,319.
Dosing and timing of the antagonist may have caused these
conflicting observations. In this regard, a possible agonistic
activity of PD123,319 on the AT1 receptor limits the definite
conclusion about the functional importance of the AT2
receptor in chronic kidney disease derived from these studies.
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Figure 8 | Glomerular size. No significant difference in
glomerular size (micrometer3 106) was found between wild-type
and knockout control mice. Glomerular size increased after renal
ablation, but again no significant difference was found between
wild-type and knockout mice.
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Figure 9 | Real-time RT-PCR analysis of renin, eNOS mRNA expression, and ADMA. No significant difference was found for renal renin
expression between knockout and wild-type control mice or between knockout and wild-type mice after renal ablation (a). In addition, no
significant difference was found between wild-type and knockout control mice for eNOS expression. eNOS expression increased after renal
ablation and induction of eNOS was significantly higher in knockout compared with wild-type mice (b). Moreover, plasma concentrations of
ADMA and symmetric dimethylarginine were measured in mice (c, d).
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Moreover, interpretation of the above-mentioned data is
hampered by the effect of the AT2 receptor antagonist on
blood pressure. In this context, it is unclear, whether the
increased injury after application of the AT2 receptor
antagonist in the study by Vazquez et al. was because of
higher blood pressure or because of blood pressure-
independent anti-fibrotic effects of the AT2 receptor. In
contrast, the knockout approach used in this study
circumvents evident problems of studies using AT2 receptor
antagonists, for example, the pleiotropic effects of AT2
receptor antagonists.
An increased mortality was found in the knockout mice
after renal ablation. The exact reason remains to be
examined. However, two mice suffering from terminal
disease were killed before the end of the experiment. Blood
urea nitrogen levels of these mice were 258 and 421 mg/
100 ml, underlining that uremia may be the cause for lethality
in these mice. It is noteworthy that mortality in this study
strongly increased 4–6 weeks after renal ablation, whereas the
data on renal function and histology were obtained 4 weeks
after renal ablation to avoid an underestimation of the renal
injury because of survival of the fittest.
Why do the knockout mice develop more renal injury and
pronounced proteinuria in comparison with wild-type mice?
In this regard, AT2 receptor-mediated changes in systemic
blood pressure may be of relevance as treatment of rats with
an AT2 receptor antagonist increases blood pressure23, and
mice lacking the AT2 receptor show pressor hypersensitivity
to Ang II.24 However, we could not detect a significant
difference in systemic blood pressure between knockout and
wild-type mice after renal ablation using telemetry as the
gold standard of blood pressure measurement in mice. These
findings render unlikely the possibility that the increased
injury in the knockout mice was simply because of higher
blood pressure. Our study is in line with earlier studies
showing no difference in basal blood pressure between AT2
receptor knockout and wild-type mice on the FVB/N
background.12,19 AT2 receptor knockout mice generated on
a C57BL/6 background were found to be mildly hypertensive
at rest.25,26 However, we cannot rule out that intrarenal
hemodynamic changes are responsible for the enhanced renal
injury observed in the AT2 receptor knockout mice. At least
in the rat, the morphological changes after renal ablation are
caused by an increased single nephron glomerular filtration
rate and increased glomerular transcapillary hydraulic
pressure.27 One may speculate that an AT2 receptor
deficiency leads to increased postglomerular vasoconstriction
by Ang II, resulting in increased intraglomerular pressure.
Moreover, increasing levels of the endogenous nitric oxide
synthase inhibitor, ADMA, as measured in knockout mice
after renal ablation, may detrimentally affect intrarenal
hemodynamics in mice of this genotype.
As suggested recently, the loss of the AT2 receptor in
knockout mice may result in an enhanced expression of the
AT1 receptor.28 This would render the mice more sensitive to
the deleterious effects of renal ablation. Expression increased
in both genotypes after ablation. However, there was no
statistically significant difference between knockout and wild-
type mice after renal ablation. In addition, renal expression of
the AT1 receptor on the protein level was not higher in
knockout mice as compared with that observed in wild-type
mice. AT2 receptor knockout mice develop increased brain
injury after ischemic stroke. It is interesting that treatment of
these mice with an AT1 antagonist was less protective in the
AT2 knockout mice than that in the wild-type mice.29 This
finding also argues against the concept that overexpression of
the AT1 receptor causes increased injury in the AT2 receptor
knockout mice. Nevertheless, more work is necessary to
evaluate the spatial and time-dependent manner of renal AT1
receptor expression before and after induction of chronic
kidney disease in our model.
Despite heavy proteinuria, electron microscopy showed no
visible damage of basement membranes and podocytes.
Interestingly, models with endothelial dysfunction that can
lead to proteinuria without foot process effacement have
been described.30 Our earlier in vitro data point to a role of
the AT2 receptor in endothelial cell function.31
Expression of AT2 receptors is high in fetal tissue but
decreases during adolescence.32 Therefore, one may argue
that the increased mortality and morbidity in the knockout
mice was not caused by the absence of the AT2 receptor
after renal ablation but because of subtle morphological
or functional subclinical injury in the kidneys acquired
during development. This problem is inherent in any
knockout-based study, but especially important in this
study as the AT2 receptor is highly expressed during
development. To avoid developmental bias, the best approach
would be to create a conditional AT2 receptor knockout
mouse model that allows for ubiquitous or organ specific
elimination of the AT2 receptor in the adult organism.
However, at least to our knowledge, such a mouse line does
not exist to date.
Postrenal problems such as ureteropelvic and ureterove-
sical stenosis with an incidence as low as 3% acquired during
development have been described in AT2 receptor knockout
mice on the C57BL/6 background.13 However, hydrone-
phrosis has not been observed in the AT2 receptor knockout
mice on the FVB/N background (unpublished observation L.
Hein). In addition, none of the mice examined in this study
showed signs of hydronephrosis. Moreover, vascular, glo-
merular, and interstitial expression of the AT2 receptor can be
found in the kidney of adult rats.33,34 Expression of the AT2
receptor in the adult can be upregulated in cardiovascular
disease suggesting that overexpression of the AT2 receptor
might represent a counter-regulatory mechanism to the
deleterious effects induced by Ang II by binding to the AT1
receptor. Indeed, increased AT2 receptor gene expression has
been shown in the kidney from 5 of 6-nephrectomized rats.23
In addition, proteinuria also upregulated AT2 receptor
expression in the kidney.35
Angiotensin I converting enzyme inhibitors and angio-
tensin receptor blockers provide only imperfect protection
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against the progression of chronic kidney disease as they
cannot always prevent end-stage renal failure. Innovative
approaches are needed to keep patients with chronic kidney
disease off dialysis.36 Our data may have clinical implications
and raise the question whether AT2 receptor agonists are
nephroprotective in chronic kidney disease. The recent
development of a selective nonpeptide AT2 receptor agonist
may aid to answer this question.37
In summary, our findings show that an AT2 receptor
deficiency increases mortality and exacerbates renal injury in
mice after renal ablation. Two possibilities arise from this
finding. On one hand, the increased injury may be caused by
altered hemodynamics in response to the renal ablation.
Increased albuminuria, fibrosis, and inflammation are then
the expected responses to the injury per se. On the other
hand, the AT2 receptor may have direct antiproteinuric,
antiinflammatory, and antifibrotic properties in chronic
kidney disease. Further studies using AT2 agonists will help
to answer this question. In addition, AT2 agonists may
represent an innovative approach for the treatment of
chronic kidney disease.
MATERIALS AND METHODS
Animal procedures and analysis of post-procedural mortality
Targeted deletion of the murine AT2 receptor gene has been
described earlier.12 For this study, AT2-deficient mice were used,
which were backcrossed for 410 generations onto a FVB/N
background. In 10-weeks-old male knockout mice and their wild-
type littermates, approximately two-thirds of the left kidney were
removed by an incision of the kidney capsule followed by ligation
under anesthesia with isoflurane. Two weeks later, the contralateral
kidney was removed. Mortality after renal ablation was studied in a
total of 25 knockout and 24 wild-type mice. For survival analysis,
only mice surviving the first week after removal of the contralateral
kidney were used (n¼ 21/21). All experiments were carried out
according to national and institutional animal care and ethical
guidelines, and have been approved by the local animal committee.
Blood pressure, albuminuria
Systolic blood pressure was measured 3 weeks after renal ablation
using tail cuff impedance plethysmography (TSE Systems, Bad
Homburg, Germany) in trained unanesthetized mice prewarmed for
5–10 min as described earlier by our group.14 Radiotelemetric blood
pressure measurements were carried out as described.38 In brief, 10
days after renal ablation, the mice were anesthetized by intraper-
itoneal injection of a mixture of ketamine (120 mg/kg) and xylazine
(18 mg/kg). A cutaneous incision was made from the submandibular
region to the sternum. The left common carotid artery was isolated.
The tip of the telemetry device was inserted into the carotid lumen
and advanced to the point of lower ligation, which was released to
push the catheter forward for a total distance of 10 mm. The
telemetrical device (TA11PA-C10; Data Sciences International, St
Paul, MN, USA) was placed subcutaneously towards the left
abdominal side and fixed with a tissue adhesive. After 10 days, data
acquisition started for 1 min every 5 min for 3 weeks (Dataquest
ART data acquisition, Data Sciences International, MN, USA).
Urine collections were obtained by placing the mice in metabolic
cages for 6 h. During urine collection, the mice had access to water.
Albuminuria was measured by enzyme-linked immunosorbent assay
(Bethyl Laboratories, Montgomery, TX, USA). The urinary albumin
values were divided by urine creatinine. Creatinine and urea-N were
measured using an autoanalyzer (Hitachi 717, Roche, Mannheim
Germany).
Organ removal
Four weeks after removal of the right kidney, the animals were killed
(n¼ 8 wild-type controls, n¼ 8 knockout controls, n¼ 20 wild-
type, and n¼ 22 knockout after renal ablation). Blood was drawn
from the aorta under isoflurane anesthesia and the kidneys were
removed. The kidney slices were fixed in 4% buffered formalin. In
addition, the renal cortex was snap frozen for mRNA analysis.
Histology
The formalin-fixed kidney slices were paraffin embedded, cut into
1-mm-thick sections and stained with periodic acid Schiff.
Glomerular injury was determined using a score from 0 to 3 as
described.14 A value of 0 was given to no injury, 1 to mild injury in
less than a quarter of the glomerular tuft, a value of 2 was given
when more than a quarter of the glomerular tuft was damaged, and
3 indicated damage of the whole glomerulus. Planimetric examina-
tions of glomerular cross-sectional area (AG) were carried out by
means of a Zeiss drawing tube in combination with a semiautomatic
interactive image analysis system (Morphomat 30, Zeiss, Go¨ttingen,
Germany) as described.14 The outlines of 30 consecutively
encountered capillary tufts were traced manually and the mean
glomerular random cross-sectional area was determined. The
average glomerular tuft volume was then calculated as
volume¼ (b/k)(AG)1.5, with b¼ 1.38 and k¼ 1.1 being shape and
size distribution coefficients, respectively.39
The paraffin-embedded sections were stained with an antibody
directed against the monocyte specific markers, F4/80 (BM8, BMA,
Germany) and MAC-2 (M3/38, Cedarlane, Ontario, Canada). Tissue
sections were developed with the Vectastain ABC–AP kit (Vector
Laboratories, Burlingame, CA, USA). MAC-2-positive cells in 30
glomerular cross sections and F4/80-positive cells in 30 tubulointer-
stitial high power fields per kidney were counted by light
microscopy in a blinded manner as described.40 For electron
microscopy, kidney tissue was fixed in 4% paraformaldehyde in
0.1 M cacodylate buffer, embedded in araldite, cut with an Ultracut E
ultramicrotome (Reichert Jung, Wien, Austria), and stained with
uranyl acetate and lead citrate. The specimens were examined with a
Zeiss EM 109 electron microscope as described.14
Real-time reverse transcriptase-PCR
Total RNA from the renal cortex of the kidney was isolated as
described earlier41 and reverse-transcribed (Superscript II, Invitro-
gen) by the use of random hexamer primers. In control mice, RNA
was pooled from one to two mice, whereas after renal ablation
the cortex tissue from two to three mice was pooled for analysis.
mRNA expression was quantified using the Applied Biosystems ABI
Prism 7900 HT system (TaqMan). We carried out TaqMan reactions
in 384-well plates according to the manufacturer’s instructions
(Applied Biosystems, Foster City, CA, USA) using pre-made probes
for MCP-1 (Mm00441242_m1), RANTES (Mm01302428_m1),
fibronectin (Mm01256744_m1), eNOS (Mm01164908_m1), and
AT1 receptor (Mm01166161_m1), and renin (Mm02342889_g1).
Glyceraldehyde-3-phosphate dehydrogenase was used as an endo-
genous control (probe Mm99999915_g1). We carried out the
relative quantification of gene expression using the DDCT method
as appropriate.
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In situ hybridization
In situ hybridization procedures were carried out as described
earlier.41 The probe for MCP-1 was prepared by in vitro
transcription of subcloned cDNA. The antisense and sense RNA
transcripts were labeled with 35S-UTP (20 mCi/ml; Amersham,
Ju¨gesheim, Germany) and served as hybridization probe and
control, respectively. Free nucleotides were separated with a
Sephadex G-50 column (quick-spin columns; Roche, Mannheim,
Germany). In situ hybridization was carried out on 12 mm
cryosections of renal tissue using 5 ng of the 35S labeled antisense
and sense RNA probes. The sections were exposed overnight to
Kodak Biomax MR X-ray films. Subsequently, they were treated with
Kodak NTB-3 nuclear track Emulsion and exposed for 3 weeks,
followed by development in Kodak D19 and fixation with Kodak
Unifix. Finally, sections were stained with Mayer’s Haemalaun.
Analyses of ADMA and symmetric dimethylarginine plasma
concentrations
ADMA and symmetric dimethylarginine plasma concentrations
were determined by a liquid chromatography-tandem MS based
method. In summary, proteins of the plasma sample were
precipitated with 100 ml of acetone, and dried supernatants were
derivatized with 100 ml of 1 M HCl in 1-butanol for 17 min at 651C.
The samples were resuspended in 1 ml of water and 20 ml of the
water extract was injected into the column. Quadrupole MS
equipped with 2 Varian ProStar model 210 HPLC pumps and a
Varian analytical column (50 2.0 mm (i.d.)) packed with Polaris
C18-Ether (3 mm bead size). The mobile phases consisted of
methanol containing 0.1% formic acid (mobile phase A) and water
containing 0.1% formic acid (mobile phase B). For ionization in the
positive electrospray ionization mode, the needle and shield voltages
were set at 5850 and 400 V.
Statistical analyses
All data were tested for normal distribution using the Kolmogor-
ov–Smirnov test. Statistical analyses were carried out using one-way
analysis of variance followed by Fisher’s protected least significant
difference test or the Kruskal–Wallis test with Dunn’s multiple
comparison as appropriate. Analysis of differences in survival
between groups after renal ablation was carried out using the
logrank test. Variables are expressed as mean±s.e.m. Probability
values were considered significant at Po0.05.
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